Locus Cell Co., Ltd. is a specialist in the biotechnology and cell therapy sector. The company primarily offers contract development and manufacturing (CDMO) services for a variety of cellular products. This includes handling diverse cell types such as adipose-derived stem cells, nerve cells, chondrocytes, and fibroblasts. Furthermore, their capabilities extend to advanced manufacturing processes like 3D bioprinting for cellular constructs. Locus Cell also provides CDMO support for cutting-edge regenerative medical products, including therapies based on CAR-T, mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs).